v3.26.3
Consolidated Statements of Cash Flows Unaudited - USD ($)
$ in Thousands
 3 Months Ended
Aug. 31, 2026
Aug. 31, 2025
Cash flows from operating activities:    
Net loss $ (19,936) $ (5,540)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 19 4
Issuance costs for private placement of shares and warrants through placement agent 3,921 0
Loss on note extinguishment 12,272 0
Stock-based compensation 524 179
Prepaid expenses and other assets (593) 1,989
Accounts payable, accrued expenses, and other liabilities (3,933) 918
Net cash used in operating activities (7,726) (2,450)
Cash flows from investing activities:    
Net cash provided by/used in investing activities 0 0
Cash flows from financing activities:    
Proceeds from sale of common stock and warrants, net of issuance costs 12,233 0
Proceeds from exercise of stock options 0 21
Cash paid for note payable 0 (142)
Net cash provided by financing activities 12,233 (121)
Net change in cash and cash equivalents 4,507 (2,571)
Cash and cash equivalents at beginning of period 11,852 11,903
Cash and cash equivalents at end of period 16,359 9,332
Supplemental disclosure:    
Cash paid for interest 0 13
Non-cash investing and financing transactions:    
Issuance of common stock for interest on convertible notes 3,000 2,250
Accrued dividends on Series C and D convertible preferred stock 374 373
Warrants issued to placement agent $ 2,160 $ 0